期刊文献+

人治疗性抗体的研究进展 被引量:2

下载PDF
导出
作者 冯蕾 韩骅
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2005年第B03期49-51,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金重点项目资助(No. 434516313)
  • 相关文献

参考文献24

  • 1Khazaeli MB, Conry RM, LoBuglio AF. Human immune response to monoclonal antibodies[J]. J Immunother, 1994, 15: 42-52.
  • 2Borrebaeck CAK, Malmborg AC, Ohlin M. Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?[J]. Immunol Today, 1993, 10: 477-479.
  • 3Morrison SL, Johnson MJ, Herzenberg LA, et al. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains[J]. Proc Natl Acad Sci USA, 1984, 21: 6851-6855.
  • 4Jones PT, Dear PH, Foote J, et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse[J]. Nature, 1986, 321: 522-525.
  • 5McCafferty J, Griffiths AD, Winter G, et al. Phage antibodies: filamentous phage displaying antibody variable domains[J]. Nature, 1990, 348: 552-554.
  • 6Soderlind E, Strandberg L, Jirholt P, et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries[J]. Nat Biotechnol, 2000, 8: 852-856.
  • 7Clark M. Antibody humanization: a case of the 'Emperor's new clothes'?[J]. Immunol Today, 2000, 21: 397-402.
  • 8Brekke OH, Lset GA. New technologies in therapeutic antibody development[J]. Current Opinion Pharmacol, 2003, 3: 544-550.
  • 9Cragg, MS, French RR, Glennie MJ. Signaling antibodies in cancer therapy[J]. Curr Opin Immunol, 1999, 11: 541-547.
  • 10Farah RA, Clinchy B, Herrera L, et al . The development of monoclonal antibodies for the therapy of cancer[J]. Crit Rev Eukaryotic Gene Expr, 1998, 8: 321-356.

同被引文献22

  • 1庄振宏,李兰,孙宪连,张新艳,单超,汪世华,王宗华.抗黄曲霉毒素B1单链抗体(scFv)库的建立和筛选[J].热带作物学报,2009,30(1):64-69. 被引量:4
  • 2莫发荣,谢小薰,罗国容.抗体制备的新技术[J].医学综述,2007,13(1):4-5. 被引量:3
  • 3Kohler G,Milstein C.Continuous culture of fused cells secreting antibody of predefined specificity[J].Nature,1975,256(5517):495-497.
  • 4Khazaeli MB,Conry RM,LoBuglio AF.Human immune response to monoclonal antibodies[J].J Immunother,1994,15(1):42-52.
  • 5Borrebaeck CK,Malmborg AC,Ohlin M.Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?[J].Immunol Today,1993,14(10):477-479.
  • 6Morrison SL,Johnson MJ,Herzenberg LA,et al.Chimeric human antibody molecules:mouse antigen-binding domains with human constant region domains[J].Proc Natl Acad Sci USA,1984,81 (21):6851-6855.
  • 7Jones PT,Dear PH,Foote J,et al.Replacing the complementarity-detemining regions in a human antibody with those from a mouse[J].Nature,1986,321 (6069):522-525.
  • 8McCafferty J,Griffiths AD,Winter G,et al.Phage antibodies:filamentous phage displaying antibody variable domains[J].Nature,1990,348(6301):552-554.
  • 9Winter G,Griffiths AD,Hawkins RE,et al.Makinq antibodies by phage display technology[J].Annu Rev Immunol,1994,12:433-455.
  • 10Benhar I.Biotechnological applications of phage and cell display[J].Biotechnol Adv,2001,19(1):1-33.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部